Lleo A. SVR is the strongest predictor of occurrence and recurrence of hepatocellular carcinoma in HCV cirrhotic patients after treatment with DAAs: A prospective multi-centric Italian study. PS-154.
Vroege follow-up van patiënten die OPAT krijgen verlaagt risico op heropname
dec 2019